SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-271969
Filing Date
2022-10-28
Accepted
2022-10-28 09:37:04
Documents
14
Period of Report
2022-10-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d406944d8ka.htm   iXBRL 8-K/A 27683
2 EX-99.1 d406944dex991.htm EX-99.1 61732
6 GRAPHIC g406944g22d00.jpg GRAPHIC 4622
  Complete submission text file 0001193125-22-271969.txt   233042

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acor-20221027.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20221027_lab.xml EX-101.LAB 18703
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20221027_pre.xml EX-101.PRE 11695
8 EXTRACTED XBRL INSTANCE DOCUMENT d406944d8ka_htm.xml XML 3845
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-31938 | Film No.: 221339290
SIC: 2836 Biological Products, (No Diagnostic Substances)